Related Experiment Video
Updated: Jun 14, 2025
08:05
Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice
Published on: June 29, 2022
2.7K
DACT2 modulates atrial fibrillation through TGF/β and Wnt signaling pathways
Bairu Luo1, Rui Zheng2, Chaoqun Shi3
1Department of Clinical Pathology, Jiaxing University Master Degree Cultivation Base, Jiaxing Hospital of Traditional Chinese Medicine, Zhejiang Chinese Medical University, Jiaxing, 314001, ZJ, China.
Heliyon
|September 3, 2024
Summary
Disheveled-associated antagonist of beta-catenin (DACT) 2 influences atrial fibrosis by modulating transforming growth factor-beta (TGF-β) and Wnt/β-catenin signaling. This research offers insights into potential treatments for atrial fibrillation (AF).
Area of Science:
- Cardiology
- Molecular Biology
- Biochemistry
Background:
- Atrial fibrillation (AF) is a prevalent cardiac arrhythmia impacting patient quality of life.
- Cardiac fibrosis is a key factor in AF onset and progression.
- Transforming growth factor-beta (TGF-β) and Wnt/β-catenin pathways are implicated in cardiac fibrosis.
Purpose of the Study:
- To investigate the role of Disheveled-associated antagonist of beta-catenin (DACT) 2 in atrial fibrosis.
- To elucidate how DACT2 influences TGF-β and Wnt/β-catenin signaling in the context of atrial fibrosis.
- To explore potential therapeutic targets for AF based on DACT2's function.
Main Methods:
- Focus on the effect of DACT2-guided β-catenin on atrial fibrosis.
- Analysis of molecular signaling pathways involved in fibrosis.
- Experimental models to study cardiac fibrosis progression.
Main Results:
- DACT2 regulates the phosphorylation of target proteins within the Wnt/β-catenin and TGF-β pathways.
- DACT2's modulation of these pathways impacts the activation of fibroblasts into myofibroblasts.
- Evidence suggests DACT2 plays a significant role in the development of atrial fibrosis.
Conclusions:
- DACT2 is a key regulator of atrial fibrosis through its interaction with β-catenin and TGF-β signaling.
- Targeting DACT2 may offer a novel therapeutic strategy for managing AF.
- Further research into DACT2's mechanisms could lead to improved AF treatments.
Related Concept Videos
01:16TGF - β Signaling Pathway
7.3K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.3K
01:17Intracellular Signaling Affects Focal Adhesions
2.6K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.6K
01:41Non-Canonical Wnt Signaling Pathways
7.3K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.3K
02:54Canonical Wnt Signaling Pathway
8.7K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.7K
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
719
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
719
01:20The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K